Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03774797 · ClinicalTrials.gov registry record
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
A clinical trial of Pregnancy Related, sponsored by University of Michigan.
- Completed
- Registry status
- 592
- Enrollment target
- 1
- Study location
NCT03774797: Completed study of Pregnancy Related, sponsored by University of Michigan.
NCT03774797 is a study of Pregnancy Related that has completed, run by University of Michigan. The registered enrollment target is 592 participants, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03774797, a study of Pregnancy Related, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 592 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women who desire it.
Primary Outcome
Patient online surveys about their experience of care during prenatal visits, hospital stay, or postpartum office visit
Conditions Studied
Interventions
- OTHER Implementation Toolkit
Study Locations (1)
Michigan
- Michigan Medicine - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2020-08-16 |
What the finished NCT03774797 record still lists
NCT03774797 is an observational study that tracks outcomes without assigning an intervention. The registered 592 participants enrollment target is mid-sized for trials with a published cap, below the 1,957-participant average among 99 other Pregnancy Related trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Pregnancy Related appearing as the primary indexed condition, and to 1 intervention - of which Implementation Toolkit is the first listed.
NCT03774797 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03774797 about?
NCT03774797 is a clinical study titled "Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation". The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unintended pregnancy soon after childbirth by increasing access to immediate postpartum LARC for women w...
What is the current status of trial NCT03774797?
This trial is currently completed. The enrollment target is 592 participants. The study started on 2018-09-01. Estimated completion is 2020-08-16.
What conditions does trial NCT03774797 study?
This clinical trial studies the following conditions: Pregnancy Related.
What interventions are being tested in trial NCT03774797?
The interventions under investigation include: Implementation Toolkit (OTHER).
Who is sponsoring clinical trial NCT03774797?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03774797 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03774797's enrollment target sits among peer trials
592 24th of 99 higher than 76 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
-
Mobile Application-based Exercise Intervention for Pregnant Women
RECRUITING · NA
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI